Cargando…
Prostate cancer immunotherapy: Improving clinical outcomes with a multi-pronged approach
Cancer immunotherapy has gained traction in recent years owing to remarkable tumor clearance in some patients. Despite the notable success of immune checkpoint blockade (ICB) in multiple malignancies, engagement of the immune system for targeted prostate cancer (PCa) therapy is still in its infancy....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591038/ https://www.ncbi.nlm.nih.gov/pubmed/37738978 http://dx.doi.org/10.1016/j.xcrm.2023.101199 |